Opinion|Videos|July 1, 2024
Future Directions for Imaging and Biopsy in Prostate Cancer
The panel offers key takeaways on the evolving landscape for imaging and biopsy in prostate cancer, highlighting the role for fusion-guided biopsy in the diagnosis and management of prostate cancer.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- What clinical challenges and unmet needsremain regarding biopsy options in the diagnosis and management of patients with prostate cancer?
- What’s next? Are there any emerging technologies or data that you’re excited about in this area? Is there a role for fusion-guided biopsy with PSMA PET imaging in prostate cancer?
- Please share any closing thoughts or key takeaways regarding the use of fusion-guidedbiopsy in the diagnosis and management of prostate cancer?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Urologist explains science behind HA penile injections
2
FDA approves label changes for first batch of menopausal hormone therapy products
3
Dual AR blockade shows promise for treatment-naïve mHSPC
4
Pearls & Perspectives: Elevating Survivorship in Urologic Care, with Bruce R. Kava, MD
5